Vismia cayennensis

Vismia cayennensis · Accepted scientific name

Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆

Vismia cayennensis is a botanical species that has gained significant scientific interest due to its diverse therapeutic potential. Researchers have focused on its leaves, specifically utilizing hexane extracts to isolate potent bioactive compounds. These extracts contain key chemical constituents such as physcion and vismiaquinone, which drive the plant's biological efficacy. Extensive studies have demonstrated that the plant possesses notable anthelmintic, anti-HIV, antibacterial, and anticancer activities. Furthermore, it has shown particular promise in addressing medical conditions such as Leishmania infection.

Quick facts
Synonyms
Caopia Cayennensis · Vismia Floribunda · 1 more
Common names
Not available
Family
Hypericaceae
Distribution
Southern America
Plant Parts
Leaf

Classification

Common Names

Vismia cayennensis is a versatile plant known by a diverse array of regional and common names. It is frequently referred to as the Black Kiskadee or simply the Kiskadee in various botanical circles. In certain locales, the species is identified by the names La Craie or Lacre. Residents of Trinidad and Tobago specifically call this plant the Yellow Wattle. These varied designations highlight the plant's widespread recognition across different cultures and geographies.

Sources: Catalogue of Life (COL)

Synonyms

Vismia cayennensis is a botanical species known to be associated with several different scientific names. In various taxonomic records, it is frequently identified by the synonym Caopia cayennensis. Researchers have also documented the plant under the name Hypericum cayennense in certain contexts. Additionally, the name Vismia floribunda serves as another recognized synonym for this specific plant. Understanding these overlapping designations is essential for maintaining accuracy in botanical classification.

Sources: The World Checklist of Vascular Plants (WCVP)

Taxonomy

Vismia cayennensis is a distinctive member of the kingdom Plantae. Within this vast botanical realm, it belongs to the class Equisetopsida. This species is further categorized under the order Malpighiales, showcasing its evolutionary connections. It resides specifically within the genus Vismia, a group defined by unique biological traits. Finally, its classification is completed by its placement in the family Hypericaceae.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Malpighiales
Family Hypericaceae
Genus Vismia

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Vismia cayennensis is a versatile plant species with a broad geographic presence across much of Southern America. Its distribution includes extensive coverage throughout Brazil, specifically within the northern and northeastern regions. The plant also thrives in the Caribbean, with documented occurrences in Trinidad and Tobago. Further north, it can be found inhabiting the landscapes of French Guiana and Guyana. This wide range highlights the species' ability to adapt to various tropical environments across the continent.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Vismia cayennensis is a self-supporting plant that takes the form of a sturdy tree. Depending on its specific environmental conditions, this species typically reaches a maximum height of 10 meters. However, under optimal growth circumstances, it can extend to a height of up to 18 meters. This versatile growth pattern allows it to establish a significant presence within its native habitat.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Compounds

Vismia cayennensis is a medicinal plant species known for its significant therapeutic potential in traditional Amazonian medicine. Research into its chemical composition has revealed that this plant contains the anthraquinone compound vismiaquinone. This specific molecule, along with others found in the genus, has demonstrated notable activity against Leishmania parasites. By inducing oxidative stress and mitochondrial dysfunction, these compounds work to effectively combat the infection. Such findings scientifically validate the traditional use of the species and highlight its value in developing new treatments for neglected diseases.

Conditions

Vismia cayennensis serves as a medicinal resource capable of treating Leishmania infection. This plant demonstrates significant antiprotozoal activity by effectively treating amastigotes. Furthermore, its extracts are successful in treating promastigotes of L. amazonensis. Beyond targeting the parasite, Vismia cayennensis is traditionally used for its ability to treat skin lesions. These combined properties highlight its therapeutic potential against cutaneous leishmaniasis.

Preparations

Vismia cayennensis is prepared as hexane extracts through a process of static maceration with n-hexane. These specific extracts are derived from the leaves of the plant to investigate their medicinal properties. Researchers utilized these hexane-based preparations to explore antiprotozoal potential against Leishmania amazonensis. The study focused on the activity of these extracts to see if they could effectively target parasite survival. Ultimately, the preparation of Vismia cayennensis as a hexane extract serves to scientifically validate its traditional use in Amazonian medicine.

Parts used

Vismia cayennensis is a plant species of the Hypericaceae family that holds significant medicinal promise in traditional Amazonian medicine. Research has specifically focused on the chemical properties of its leaves, which are utilized to create potent hexane extracts. These leaf extracts contain valuable compounds such as vismiaquinone, which contribute to the plant's biological activity. Scientific investigations demonstrate that these components can effectively target parasites, supporting the plant's historical use in treating skin lesions. Ultimately, the study of the leaves of Vismia cayennensis highlights its potential as a natural resource for developing new antileishmanial drugs.